Search - Institut de cancérologie de l'Ouest Access content directly

Filter your results

199 Results
Deposit type : Notice

Etude de phase II sur l’efficacité et la tolérance d’une augmentation de dose de radiothérapie des lésions hypoxiques définies par TEP-scanographie au fluoromisonidazole chez les patients suivis pour un cancer bronchique non à petites cellules

Sébastien Thureau , Philippe Chaumet Riffaud , Romain Modzelewski , Sébastien Hapdey , Marc Mahé , et al.
Congrès de la Société Française de Radiothérapie et Oncologie, 2016, Paris, France
Conference poster hal-01665300v1

Phase I dose-escalation trial of afatinib, an irreversible ErbB family blocker, in combination with gemcitabine or docetaxel in patients with relapsed or refractory solid tumors

Sandrine Hiret , Nicolas Isambert , Carlos Gomez-Roca , Jaafar Bennouna , Mouna Sassi , et al.
Investigational New Drugs, 2018, 36 (6), pp.1044-1059. ⟨10.1007/s10637-018-0601-1⟩
Journal articles hal-01960201v1

A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib

Nicolas Penel , Olivier Mir , Jennifer Wallet , Isabelle Ray-Coquard , Axel Le Cesne , et al.
European Journal of Cancer, 2020, 126, pp.45-55. ⟨10.1016/j.ejca.2019.12.001⟩
Journal articles hal-03623680v1

Exercise training improves radiotherapy efficiency in a murine model of prostate cancer

Suzanne Dufresne , Jordan Guéritat , Sophie Chiavassa , Caroline Noblet , Mohamad Assi , et al.
FASEB Journal, 2020, 34 (4), pp.4984-4996. ⟨10.1096/fj.201901728R⟩
Journal articles hal-02498421v1

Predictive Power of FDG-PET Parameters at Diagnosis and after Induction in Patients with Mantle Cell Lymphoma, Interim Results from the LyMa-PET Project, Conducted on Behalf of the Lysa Group

Caroline Bodet-Milin , Clément Bailly , Michel Meignan , Alina Beriollo-Riedinger , René-Olivier Casasnovas , et al.
Blood, 2015, 126 (23), pp.335
Journal articles hal-01300802v1

Impact of body mass index on overall survival in patients with metastatic breast cancer

Khalil Saleh , Matthieu Carton , Véronique Dieras , Pierre-Etienne Heudel , Etienne Brain , et al.
Breast, 2021, 55, pp.16-24. ⟨10.1016/j.breast.2020.11.014⟩
Journal articles hal-03345238v1

Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas

Maud Toulmonde , Nicolas Penel , Julien Adam , Christine Chevreau , Jean-Yves Blay , et al.
JAMA oncology, 2018, 4 (1), pp.93-97. ⟨10.1001/jamaoncol.2017.1617⟩
Journal articles hal-01708092v1

Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups

I. Amblard , F. Mercier , D.L. Bartlett , S.A. Ahrendt , K.W. Lee , et al.
EJSO - European Journal of Surgical Oncology, 2018, 44 (9), pp.1378-1383. ⟨10.1016/j.ejso.2018.04.023⟩
Journal articles hal-02281342v1

Postoperative irinotecan in resected stage II-III rectal cancer: final analysis of the French R98 Intergroup trial

C. Delbaldo , M. Ychou , A. Zawadi , J. Douillard , T. André , et al.
Annals of Oncology, 2015, 26 (6), pp.1208-1215. ⟨10.1093/annonc/mdv135⟩
Journal articles hal-02285403v1

Standard or accelerated methotrexate, vinblastine, doxorubicin and cisplatin as neoadjuvant chemotherapy for locally advanced urothelial bladder cancer: Does dose intensity matter?

Damien Pouessel , Sylvie Chevret , Frédéric Rolland , Gwenaëlle Gravis , Lionel Geoffrois , et al.
European Journal of Cancer, 2016, 54, pp.69--74. ⟨10.1016/j.ejca.2015.11.017⟩
Journal articles hal-01278607v1

Post-Prostatectomy Image-Guided Radiotherapy: The Invisible Target Concept

Florent Vilotte , Mickael Antoine , Maxime Bobin , Igor Latorzeff , Stéphane Supiot , et al.
Frontiers in Oncology, 2017, 7, pp.34. ⟨10.3389/fonc.2017.00034⟩
Journal articles hal-01502241v1

Updated Incidence of Thymic Epithelial Tumors (TET) in France and Clinical Presentation at Diagnosis

Maria Bluthgen , Eric Dansin , Mallorie Kerjouan , Julien Mazieres , Eric Pichon , et al.
Journal of Thoracic Oncology, 2017, 12 (1, S), pp.S1000. ⟨10.1016/j.jtho.2016.11.1386⟩
Journal articles hal-01774363v1

Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil–cisplatin regimen in oesophageal cancer

C. Bascoul-Mollevi , S. Gourgou , M.-P. Galais , J.-L. Raoul , O. Bouche , et al.
European Journal of Cancer, 2017, 84, pp.239 - 249. ⟨10.1016/j.ejca.2017.07.038⟩
Journal articles hal-01688845v1

Validation of the prognostic impact of lymphocyte infiltration (LI) in patients (pts) with stage III colon cancer (CC) treated with adjuvant FOLFOX plus /- cetuximab: A PETACC8 translational study

Jean-François Emile , Karine Le Malicot , Josep Tabernero , Enrico Mini , Gunnar Folprecht , et al.
Gastrointestinal Cancers Symposium, ASCO University, Jan 2016, San Francisco, United States. pp.Meeting Abstract: 553
Conference papers hal-01490356v1

Chemotherapy for Muscle-invasive Bladder Cancer: Impact of Cisplatin Delivery on Renal Function and Local Control Rate in the Randomized Phase III VESPER (GETUG-AFU V05) Trial

Stéphane Culine , Valentin Harter , Gwenaelle Gravis , Aude Fléchon , Christine Chevreau , et al.
Clinical Genitourinary Cancer, 2021, 19 (6), pp.554-562. ⟨10.1016/j.clgc.2021.08.005⟩
Journal articles hal-03625944v1

Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors

Sabrina Croce , Agnès Ducoulombier , Agnès Ribeiro , Tom Lesluyes , Jean-Christophe Noel , et al.
Modern Pathology, 2018, 31 (5), pp.816 - 828. ⟨10.1038/modpathol.2017.185⟩
Journal articles hal-01926566v1

EP-1998: In silico modelling of the impact of the fractionation for hypofractionated prostate treatments

G. Delpon , J. N'Guessan , Perrine Paul-Gilloteaux , K. Clément-Colmou , V. Potiron , et al.
Radiotherapy & Oncology, 2018, 127 (S2), pp.S1086-S1087. ⟨10.1016/S0167-8140(18)32307-7⟩
Journal articles hal-02736053v1

Delineation guidelines for the lymphatic target volumes in ‘prone crawl’ radiotherapy treatment position for breast cancer patients

Guillaume Janoray , Yoann Pointreau , Marc Alfonsi , Christian Sire , Lionel Geoffrois , et al.
Scientific Reports, 2021, 11 (1), pp.22529. ⟨10.1038/s41598-021-01841-y⟩
Journal articles hal-03657494v1

Mitotic stress-induced secretome primes cancer cells to apoptosis and maximizes paclitaxel response in breast tumors when combined with BCL-xL-targeting BH3 mimetics

Steven Lohard , Philippe Juin , Sophie C Barillé-Nion
Molecular & Cellular Oncology, 2020, 7 (3), pp.1735912. ⟨10.1080/23723556.2020.1735912⟩
Journal articles inserm-03319352v1

Faecal calprotectin is highly effective to detect endoscopic ulcerations in Crohn's disease regardless of disease location

A. Buisson , W. Y. Mak , M. J. Andersen , D. Lei , J. Pekow , et al.
13. Congress of ECCO - European Crohn's and Colitis Organisation, Feb 2018, Vienne, Austria
Conference papers hal-02734755v1

Emotional processes in partners’ quality of life at various stages of breast cancer pathway: a longitudinal study

Anne-Sophie Baudry , Laurence Vanlemmens , Anne Congard , Aurélie Untas , Carine Segura-Djezzar , et al.
Quality of Life Research, 2022, ⟨10.1007/s11136-022-03298-6⟩
Journal articles hal-03991505v1

Efficacy and Safety of First-line Single-Agent Carboplatin vs Carboplatin Plus Paclitaxel for Vulnerable Older Adult Women With Ovarian Cancer: A GINECO/GCIG Randomized Clinical Trial

C. Falandry , F. Rousseau , M. A. Mouret-Reynier , F. Tinquaut , D. Lorusso , et al.
JAMA oncology, 2021, 7 (6), pp.853-861. ⟨10.1001/jamaoncol.2021.0696⟩
Journal articles inserm-03344388v1

Comprehensive Geriatric Assessment and quality of life after localized prostate cancer radiotherapy in elderly patients

Aurore Goineau , Loïc Campion , Bénédicte d'Aillières , Brigitte Vié , Agnès Ghesquière , et al.
PLoS ONE, 2018, 13 (4), pp.e0194173. ⟨10.1371/journal.pone.0194173⟩
Journal articles hal-03612970v1

Pediatric Localized Intracranial Ependymomas: A Multicenter Analysis of the Société Française de lutte contre les Cancers de l'Enfant (SFCE) from 2000 to 2013

Anne Ducassou , Laetitia Padovani , Leonor L. Chaltiel , Stéphanie Bolle , Jean-Louis Habrand , et al.
International Journal of Radiation Oncology, Biology, Physics, 2018, 102 (1), pp.166-173. ⟨10.1016/j.ijrobp.2018.05.036⟩
Journal articles hal-02478966v1

Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefit

Alexandre de Nonneville , Camille Jauffret , Anthony Gonçalves , Jean-Marc Classe , Monique Cohen , et al.
Breast Cancer Research and Treatment, 2019, 175 (2), pp.379-387. ⟨10.1007/s10549-019-05160-9⟩
Journal articles hal-02419353v1

Brief report: High prevalence of somatic oncogenic driver alterations in non-small cell lung cancer patients with Li-Fraumeni Syndrome

Laura Mezquita , Maria Jove , Ernest Nadal , Maria Kfoury , Teresa Morán , et al.
Journal of Thoracic Oncology, 2020, 15 (7), pp.1232-1239. ⟨10.1016/j.jtho.2020.03.005⟩
Journal articles hal-02534435v1

Localized Myxofibrosarcomas: Roles of Surgical Margins and Adjuvant Radiation Therapy

Raoudha Boughzala-Bennadji , Eberhard Stoeckle , Cécile Le Péchoux , Pierre Méeus , Charles Honoré , et al.
International Journal of Radiation Oncology, Biology, Physics, 2018, 102 (2), pp.399-406. ⟨10.1016/j.ijrobp.2018.05.055⟩
Journal articles hal-02049039v1

[COVID-19 and People Followed for Breast Cancer: French Guidelines for Clinical Practice of Nice-St Paul De Vence, in Collaboration With the Collège Nationale Des Gynécologues Et Obstétriciens Français (CNGOF), the Société d'Imagerie De La Femme (SIFEM), the Société Française De Chirurgie Oncologique (SFCO), the Société Française De Sénologie Et Pathologie Mammaire (SFSPM) and the French Breast Cancer Intergroup-UNICANCER (UCBG)]

Joseph Gligorov , Thomas Bachelot , Jean-Yves Pierga , Eric-Charles Antoine , Corinne Balleyguier , et al.
Bulletin du Cancer, 2020, 107 (5), pp.528-537. ⟨10.1016/j.bulcan.2020.03.008⟩
Journal articles hal-02869600v1

Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study

A. de Nonneville , A. Goncalves , C. Zemmour , M. Cohen , J.M. Classe , et al.
European Journal of Cancer, 2017, 84, pp.34-43. ⟨10.1016/j.ejca.2017.06.043⟩
Journal articles hal-02282824v1

Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial

Amit Oza , Ursula Matulonis , Susanne Malander , Stacie Hudgens , Jalid Sehouli , et al.
Lancet Oncology, 2018, 19 (8), pp.1117-1125. ⟨10.1016/S1470-2045(18)30333-4⟩
Journal articles hal-02283098v1